{{projects[437673].description}}
{{projects[437541].description}}
{{projects[437512].description}}
{{projects[437459].description}}
{{projects[437499].description}}
{{projects[437511].description}}
{{projects[437451].description}}
{{projects[437453].description}}
{{projects[437407].description}}
{{projects[437362].description}}
{{projects[437273].description}}
{{projects[437277].description}}
{{projects[437295].description}}
{{projects[437270].description}}
{{projects[437253].description}}
{{projects[436635].description}}
{{projects[437200].description}}
{{projects[437076].description}}
{{projects[437058].description}}
{{projects[436890].description}}
{{projects[436853].description}}
{{projects[436822].description}}
{{projects[436706].description}}
{{projects[436700].description}}
{{projects[434441].description}}
{{projects[436673].description}}
{{projects[436642].description}}
{{projects[436648].description}}
{{projects[436628].description}}
{{projects[436619].description}}
{{projects[436612].description}}
{{projects[436616].description}}
L’objectif de cette étude est d’étudier l’efficacité clinique de la carboxythérapie guidée par ultrasons comme traitement conservateur du syndrome génito-urinaire de la ménopause, un des problèmes difficiles rencontrés par les gynécologues.
{{projects[436566].description}}
{{projects[436560].description}}
{{projects[432579].description}}